Home   Sitemap   Contact Us
 
Hot Topics

Why Fruit Flies?

Many biomedical research efforts use mice or rats as animal models; at Genescient we focus on fruit flies (Drosophila), with a methodology of taking discoveries made using flies and then testing them on rodents and humans.

One reason is that, due to their short lifespan, it is possible to evolve many generations of fruit flies in a relatively short time period. Genescient’s long-lived fly populations are the result of experimental evolution over 30 years, which represents about 800 standard generations of fruit flies. To evolve mice over a comparable number of generations would take about 200 years. Carrying out experimental evolution over so many generations results in populations with extremely strong genetic differences from control populations, providing strikingly clean data that our statistical and AI algorithms can then analyze to make novel discoveries.

Another reason Genescient uses Drosophila is that specific pathophysiological phenotypes are readily evaluated in the fruit fly. For instance there are straightforward ways to test the strength of a fly’s cardiovascular or neurological system, and to test the impact of cardio or neuro drugs on flies.

Using fruit flies as a model organism allows us to more rapidly unravel the complexity of biological networks, many of which have similar structure and dynamics across flies, mice and humans. Thus fruit flies are an extremely powerful tool for the development of effective disease therapies.

For an example of the use of Drosophila experimental evolution to produce genome-wide differentiation, see: Genome-wide analysis of a long-term evolution experiment with Drosophila. 2010. Molly K. Burke, Joseph P. Dunham, Parvin Shahrestani, Kevin R. Thornton, Michael R. Rose & Anthony D. Long. Nature (2010) doi:10.1038/nature09352.

Recent News

AIs, Superflies, and the Path to Immortality

Interpretation of genetic data from fruit flies bred for longevity suggests the major culprit [behind poor health, disease and limited [...]

Read Full Article »
Genescient Receives Additional Angel Funding

Genescient Corporation, a California genomic-health biotechnology company, received $500,000 in new angel investment, to help commercialize the company’s technology and to fund further research.

Read Full Article »

Recent Publications

Adaptation, Aging, and Genomic Information

Aging is not simply an accumulation of damage or inappropriate higher-order signaling. Aging occurs because of the extensive absence of adaptive genomic information

Read Full Article »
Evolution of ageing since Darwin

Evolutionary biology provides the only cogent, formally developed, and experimentally corroborated theory for biological ageing. In this essay, we supply a brisk run through the highlights of evolutionary research on the biology of ageing.

Read Full Article »